Literature DB >> 33725266

Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation.

Mai Azuma1, Shingo Kato2, Ryusuke Sekii1, Sho Kodama1, Kei Kinoshita1, Keisuke Suzurikawa1, Minako Kagimoto1, Naoki Nakayama1, Kohei Iguchi1, Kazuki Fukui1, Tae Iwasawa3, Daisuke Utsunomiya4, Kazuo Kimura5, Kouichi Tamura6.   

Abstract

Absence of myocardial fibrosis on late gadolinium enhanced (LGE) magnetic resonance imaging (MRI) is associated with improvement of left ventricular systolic function after catheter ablation (CA) for atrial fibrillation (AF) with non-ischemic dilated cardiomyopathy (NIDCM). Extracellular volume fraction (ECV) by T1 mapping has emerges as a non-invasive mean to quantify severity of myocardial fibrosis. The aim of this study was to assess the incremental value of ECV over LGE-MRI for the improvement of LVEF(∆EF) after CA in NIDCM patients. A total of thirty-two patients with NIDCM and AF (mean age 67.4 ± 9.3 years; 29 (91%) male) were retrospectively studied. Using a 1.5 T MR scanner and 32 channel cardiac coils, LGE-MRI, pre- and post-T1 mapping images of LV wall at mid-ventricular level (modified look-locker inversion recovery sequence) were acquired. All patients successfully underwent CA for AF, and the improvement of LVEF after CA were evaluated by echocardiography. All patients restored sinus rhythm after CA at the time of echocardiography. The mean LVEF was 35.1 ± 9.7% before CA and 52.2 ± 10.2% after CA (p < 0.001), resulting an increase of 17.4 ± 12.6%. Significant correlation was found between ∆LVEF and % LGE (r = - 0.49, p = 0.004), ∆LVEF and extracellular volume fraction (ECV) (r = - 0.47, p = 0.010). Area under the receiver operating characteristics curve (AUC) of combination of %LGE and ECV for predicting improvement of LVEF > 10% was substantially higher than that of %LGE alone (AUC: 0.830 vs 0.602). In NIDCM patients with AF, ECV had incremental value over %LGE for predicting improvement of EF by CA, suggesting that the assessment of diffuse interstitial fibrosis may be important to forecast the response of CA.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Extracellular volume fraction; Magnetic resonance; Non-ischemic dilated cardiomyopathy; T1 mapping

Year:  2021        PMID: 33725266     DOI: 10.1007/s10554-021-02219-x

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  20 in total

1.  Prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy: comparison of 123I-MIBG scintigraphy and low-dose dobutamine stress echocardiography.

Authors:  Konghow Lee; Masao Daimon; Youichi Kuwabara; Rei Hasegawa; Tomohiko Toyoda; Tai Sekine; Takayuki Kawata; Issei Komuro
Journal:  J Echocardiogr       Date:  2009-09-11

2.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt
Journal:  J Am Soc Echocardiogr       Date:  2015-01       Impact factor: 5.251

3.  Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.

Authors:  Shiro Nakamori; Kaoru Dohi; Masaki Ishida; Yoshitaka Goto; Kyoko Imanaka-Yoshida; Taku Omori; Itaru Goto; Naoto Kumagai; Naoki Fujimoto; Yasutaka Ichikawa; Kakuya Kitagawa; Norikazu Yamada; Hajime Sakuma; Masaaki Ito
Journal:  JACC Cardiovasc Imaging       Date:  2017-06-14

4.  Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis.

Authors:  Leah M Iles; Andris H Ellims; Huw Llewellyn; James L Hare; David M Kaye; Catriona A McLean; Andrew J Taylor
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-10-28       Impact factor: 6.875

5.  Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study.

Authors:  Sandeep Prabhu; Andrew J Taylor; Ben T Costello; David M Kaye; Alex J A McLellan; Aleksandr Voskoboinik; Hariharan Sugumar; Siobhan M Lockwood; Michael B Stokes; Bhupesh Pathik; Chrishan J Nalliah; Geoff R Wong; Sonia M Azzopardi; Sarah J Gutman; Geoffrey Lee; Jamie Layland; Justin A Mariani; Liang-Han Ling; Jonathan M Kalman; Peter M Kistler
Journal:  J Am Coll Cardiol       Date:  2017-08-27       Impact factor: 24.094

6.  Catheter Ablation for Atrial Fibrillation with Heart Failure.

Authors:  Nassir F Marrouche; Johannes Brachmann; Dietrich Andresen; Jürgen Siebels; Lucas Boersma; Luc Jordaens; Béla Merkely; Evgeny Pokushalov; Prashanthan Sanders; Jochen Proff; Heribert Schunkert; Hildegard Christ; Jürgen Vogt; Dietmar Bänsch
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

Review 7.  Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction.

Authors:  Stephen B Wilton; Adam Fundytus; William A Ghali; George D Veenhuyzen; F Russell Quinn; L Brent Mitchell; Michael D Hill; Peter Faris; Derek V Exner
Journal:  Am J Cardiol       Date:  2010-11-01       Impact factor: 2.778

8.  T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.

Authors:  Fabian aus dem Siepen; Sebastian J Buss; Daniel Messroghli; Florian Andre; Dirk Lossnitzer; Sebastian Seitz; Marius Keller; Philipp A Schnabel; Evangelos Giannitsis; Grigorios Korosoglou; Hugo A Katus; Henning Steen
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-09-22       Impact factor: 6.875

9.  Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality.

Authors:  Timothy C Wong; Kayla Piehler; Christopher G Meier; Stephen M Testa; Amanda M Klock; Ali A Aneizi; Jonathan Shakesprere; Peter Kellman; Sanjeev G Shroff; David S Schwartzman; Suresh R Mulukutla; Marc A Simon; Erik B Schelbert
Journal:  Circulation       Date:  2012-07-31       Impact factor: 29.690

Review 10.  Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review.

Authors:  Philip Haaf; Pankaj Garg; Daniel R Messroghli; David A Broadbent; John P Greenwood; Sven Plein
Journal:  J Cardiovasc Magn Reson       Date:  2016-11-30       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.